Newly identified drug targets could open door for esophageal cancer therapeutics
Wednesday, February 27, 2019 - 18:00
in Health & Medicine
Blocking two molecular pathways that send signals inside cancer cells could stave off esophageal adenocarcinoma (EAC), the most common esophageal malignancy in the United States, according to new research.